Great Diamond Partners’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,099
Closed -$206K 237
2025
Q3
$206K Buy
+8,099
New +$200K 0.04% 222
2024
Q4
Sell
-7,031
Closed -$203K 199
2024
Q3
$203K Buy
+7,031
New +$205K 0.05% 192
2024
Q1
Sell
-7,879
Closed -$227K 237
2023
Q4
$227K Sell
7,879
-365
-4% -$11K 0.06% 213
2023
Q3
$273K Buy
8,244
+248
+3% +$8.77K 0.07% 181
2023
Q2
$293K Sell
7,996
-1,396
-15% -$54.3K 0.08% 175
2023
Q1
$383K Sell
9,392
-14,023
-60% -$606K 0.11% 140
2022
Q4
$1.2M Sell
23,415
-4,049
-15% -$194K 0.37% 67
2022
Q3
$1.2M Buy
27,464
+1,329
+5% +$64.6K 0.41% 62
2022
Q2
$1.37M Buy
26,135
+2,034
+8% +$104K 0.46% 57
2022
Q1
$1.25M Buy
24,101
+8,654
+56% +$449K 0.35% 68
2021
Q4
$912K Sell
15,447
-1,190
-7% -$59K 0.23% 91
2021
Q3
$715K Buy
16,637
+4,825
+41% +$214K 0.2% 100
2021
Q2
$462K Sell
11,812
-1,025
-8% -$39.9K 0.13% 127
2021
Q1
$465K Sell
12,837
-18
-0.1% -$639 0.14% 120
2020
Q4
$473K Sell
12,855
-1,686
-12% -$61.8K 0.15% 109
2020
Q3
$506K Sell
14,541
-742
-5% -$26K 0.19% 89
2020
Q2
$474K Sell
15,283
-33,853
-69% -$1.15M 0.2% 83
2020
Q1
$1.52M Sell
49,136
-2,109
-4% -$71.9K 0.78% 38
2019
Q4
$1.9M Buy
+51,245
New +$1.83M 0.72% 35

Other funds holding PFE

Great Diamond Partners's PFE Position: Q4 2025 in Review

Great Diamond Partners sold out of Pfizer (PFE) in Q4 2025, closing a stake of 8,099 shares — an estimated $206K sold.

Great Diamond Partners first reported a position in PFE in Q4 2019 and held it in 19 quarters. The position peaked at $1.9M in Q4 2019. 2,914 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Great Diamond Partners reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Great Diamond Partners sold 8,099 Pfizer shares in Q4 2025, an estimated $206K.
  • Great Diamond Partners first reported a position in Pfizer in Q4 2019 and held it in 19 quarters.
  • Great Diamond Partners's Pfizer position peaked at $1.9M in Q4 2019.
  • 2,914 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Great Diamond Partners's 13F filing for Q4 2025, filed 6 Feb 2026.